Anthony Petrone
Stock Analyst at Mizuho
(3.76)
# 760
Out of 5,022 analysts
193
Total ratings
49.64%
Success rate
8.44%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $62.56 | +11.89% | 3 | Sep 25, 2025 | |
| ALC Alcon | Maintains: Outperform | $120 → $110 | $74.08 | +48.49% | 10 | Aug 21, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $49.76 | +40.68% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $55.07 | +27.11% | 6 | Aug 7, 2025 | |
| RMD ResMed | Maintains: Outperform | $270 → $290 | $270.07 | +7.38% | 17 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $122.28 | +10.40% | 9 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $87 → $95 | $73.36 | +29.50% | 9 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $133.27 | +1.30% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $71.21 | +26.39% | 15 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $27.10 | -33.57% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $96.54 | +3.58% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $70 | $65.92 | +6.19% | 9 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $44.40 | +57.66% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $13.53 | -11.31% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $66.21 | +51.03% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $85.32 | +105.11% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.44 | +354.55% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $14.38 | +39.08% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $60.56 | -0.92% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $69.83 | -16.94% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $52.71 | +13.84% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $96.24 | +14.30% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $14.95 | -6.35% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $72.34 | +45.15% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $78.84 | +217.10% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.58 | +112.77% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $436.39 | -10.63% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $87.38 | -23.32% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $98.37 | +77.90% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.48 | +117.77% | 3 | May 13, 2020 |
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $62.56
Upside: +11.89%
Alcon
Aug 21, 2025
Maintains: Outperform
Price Target: $120 → $110
Current: $74.08
Upside: +48.49%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $49.76
Upside: +40.68%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $55.07
Upside: +27.11%
ResMed
Aug 1, 2025
Maintains: Outperform
Price Target: $270 → $290
Current: $270.07
Upside: +7.38%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $122.28
Upside: +10.40%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $87 → $95
Current: $73.36
Upside: +29.50%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $133.27
Upside: +1.30%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $71.21
Upside: +26.39%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $27.10
Upside: -33.57%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $96.54
Upside: +3.58%
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $65.92
Upside: +6.19%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $44.40
Upside: +57.66%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $13.53
Upside: -11.31%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $66.21
Upside: +51.03%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $85.32
Upside: +105.11%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.44
Upside: +354.55%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $14.38
Upside: +39.08%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $60.56
Upside: -0.92%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $69.83
Upside: -16.94%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $52.71
Upside: +13.84%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $96.24
Upside: +14.30%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $14.95
Upside: -6.35%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $72.34
Upside: +45.15%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $78.84
Upside: +217.10%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.58
Upside: +112.77%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $436.39
Upside: -10.63%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $87.38
Upside: -23.32%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $98.37
Upside: +77.90%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.48
Upside: +117.77%